| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |